GaitUp is a health technology startup that operates in the field of motion analysis. It caters to a broad market, including academic research, clinical investigations, and sports science projects. The company's primary offering is its proprietary Physilog® platform, a full-stack solution that uses wearable motion sensors and advanced algorithms to capture, measure, and analyze motion biomarkers. These biomarkers are crucial indicators of an individual's health and wellbeing, particularly for the over one billion people worldwide suffering from mobility impairments due to neurological or musculoskeletal conditions.

The Physilog® platform combines the sixth-generation wearable motion sensors, known as Physilog® 6 or P6, with powerful biomechanical fusion algorithms. It also includes a modular suite of protocolised clinical tests. This technology allows for the capture and analysis of a new generation of digital biomarkers, providing valuable data on human motion.

GaitUp's business model is based on selling its Physilog® platform to the global life science and academic research community. Since its inception in 2013, the company has built a strong reputation, with its solutions being used to assess over 10,000 subjects and referenced in more than 500 publications across 30 countries. This widespread use and recognition demonstrate the platform's reliability and effectiveness, making it a trusted tool in the field of motion analysis.

In summary, GaitUp is a health tech startup that leverages wearable technology and advanced algorithms to provide valuable insights into human motion, serving a diverse market that includes researchers, clinicians, and sports scientists.

Keywords: Health Technology, Motion Analysis, Wearable Sensors, Biomechanical Algorithms, Digital Biomarkers, Mobility Impairments, Physilog® Platform, Academic Research, Clinical Investigations, Sports Science.